Economic and social impact of migraine
- PMID: 8730346
- DOI: 10.1093/oxfordjournals.qjmed.a030141
Economic and social impact of migraine
Abstract
We sent an anonymous self-administered questionnaire to 4200 employees of a Trust hospital, 1903 of whom returned it. We identified 158 migraine sufferers according to International Headache Society (IHS) criteria. These sufferers estimated 2.0 days/year absence from work, and an equivalent of 5.5 days/year lost by reduced effectiveness at work, caused by their migraine at an estimated financial cost of over 50,000 pounds to the Trust. An additional 220 individuals who had received a diagnosis of migraine from a doctor but fulfilled only 3/4 IHS criteria lost the equivalent of 6.7 days off work at a further cost of 63,000 pounds). Few patients had consulted their general practitioner about their migraines in the last 3 months. Most (78%) were using only over-the-counter medication. Migraine patients should be encouraged to seek medical attention.
Similar articles
-
The economic burden of migraine to society.Pharmacoeconomics. 1998 Jun;13(6):667-76. doi: 10.2165/00019053-199813060-00003. Pharmacoeconomics. 1998. PMID: 10179702 Review.
-
Economic impact of migraine and other episodic headaches in France: data from the GRIM2000 study.Pharmacoeconomics. 2004;22(15):985-99. doi: 10.2165/00019053-200422150-00003. Pharmacoeconomics. 2004. PMID: 15449963
-
Workplace disability in migraine: an Italian experience.Neurol Sci. 2004 Oct;25 Suppl 3:S251-2. doi: 10.1007/s10072-004-0299-z. Neurol Sci. 2004. PMID: 15549550
-
Epidemiological aspects of headache in a workplace setting and the impact on the economic loss.Eur J Neurol. 2002 Mar;9(2):171-4. doi: 10.1046/j.1468-1331.2002.00355.x. Eur J Neurol. 2002. PMID: 11882058
-
Prevalence, burden, and clinical management of migraine in China, Japan, and South Korea: a comprehensive review of the literature.J Headache Pain. 2019 Dec 5;20(1):111. doi: 10.1186/s10194-019-1062-4. J Headache Pain. 2019. PMID: 31805851 Free PMC article. Review.
Cited by
-
Diclofenac with or without an antiemetic for acute migraine headaches in adults.Cochrane Database Syst Rev. 2012 Feb 15;2(2):CD008783. doi: 10.1002/14651858.CD008783.pub2. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2013 Apr 30;(4):CD008783. doi: 10.1002/14651858.CD008783.pub3. PMID: 22336852 Free PMC article. Updated.
-
Sumatriptan (subcutaneous route of administration) for acute migraine attacks in adults.Cochrane Database Syst Rev. 2012 Feb 15;2012(2):CD009665. doi: 10.1002/14651858.CD009665. Cochrane Database Syst Rev. 2012. PMID: 22336869 Free PMC article.
-
Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults.Cochrane Database Syst Rev. 2013 Jun 24;2013(6):CD010611. doi: 10.1002/14651858.CD010611. Cochrane Database Syst Rev. 2013. PMID: 23797677 Free PMC article.
-
Usefulness of the SF-8 Health Survey for comparing the impact of migraine and other conditions.Qual Life Res. 2003 Dec;12(8):1003-12. doi: 10.1023/a:1026179517081. Qual Life Res. 2003. PMID: 14651418
-
The economic burden of migraine to society.Pharmacoeconomics. 1998 Jun;13(6):667-76. doi: 10.2165/00019053-199813060-00003. Pharmacoeconomics. 1998. PMID: 10179702 Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical